Clinical Pharmacology & Therapeutics · 2008 · 21 citations · 32 references
Life SciencesMolecular BiologyPharmacologyCellular PharmacologyGeriatric PharmacologyInnate ImmunityAntiretroviral TherapyNatural Killer Cell RegulationEfflux Transporter ModulationGlycoprotein FunctionP-glycoprotein TransportP-glycoprotein-mediated EffluxReverse Transcription Polymerase Chain Reaction (Rt-pcr)
P-glycoprotein (P-gp) is an efflux transporter that controls the intracellular concentrations of drugs. Human development may modulate P-gp function. We investigated the effect of age on P-gp activity and MDR1 gene expression in lymphocytes. We also assessed the influence of human immunodeficiency virus (HIV) infection. We used 3,3'-diethyloxacarbocyanin iodide (DiOC(6)) efflux, estimated by flow cytometry, to quantify P-gp activity in 94 children (age range, 0-18 years) and 25 adults. MDR1 gene expression was quantified using reverse transcription-PCR (RT-PCR). In T and natural killer (NK) cell populations, P-gp activity peaked at birth, decreased between the ages of 0 and 6 months, and stabilized between the ages of 6 months and 2 years (P < 10(-6)). These maturation profiles were also strongly correlated (r = 0.67, P < 10(-6)). HIV infection did not affect P-gp activity in the lymphocytes of children. MDR1 gene expression was not influenced by age, nor was it correlated with P-gp activity. The high levels of P-gp activity observed in the lymphocytes of children ~6 months of age may affect the efficacy of intracellular drugs.
32
Sven Hoffmeyer · Proceedings of the National Academy of Sciences · 2000 · 598 citations
P-glycoprotein expression and function in circulating blood cells from normal volunteers
WT Klimecki, B W Futscher, TM Grogan et al. · Blood · 1994 · 347 citations · Full text